Sodium benzoate/clozapine

N/A

Report date: 2025/07/25 14:29:52

Base Information

Drug NameSodium benzoate/clozapine
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionD-amino-acid oxidase inhibitorsSerotonin 2a (5-HT2a) receptor antagonistsDopamine receptors antagonists
TargetsD-amino-acid oxidaseSerotonin 2a (5-HT2a) receptorDopamine receptors
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Sodium BenzoateClozapine
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSyneurx International
China Registration ClassN/A

Develop Information

Active CompaniesSyneurx International (Taiwan) Corp
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A